HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A

被引:65
作者
Chithalen, JV
Luu, L
Petkovich, M
Jones, G [1 ]
机构
[1] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada
[3] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada
关键词
vitamin A metabolism; retinoids; cytochrome P450; RAI-1;
D O I
10.1194/jlr.M100343-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two mammalian hCYP26A expression systems have been used to analyze the metabolic products of CYP26A. Through the use of extensive HPLC, UV spectroscopy, and liquid chromatography/tandem mass spectrometry (LC-MS/MS) methodology, we have conclusively demonstrated that the complex mixture of products comprises 4-OH-all-trans-retinoic acid, 4-oxo-all-trans-retinoic acid, and 18-OH-all-trans-retinoic acid, and more polar products, partially identified as dihydroxy and mono-oxo, mono-hydroxy derivatives. These more polar products are presumed to result from multiple hydroxylations on the beta-ionone ring. The inter-relationship of initial and polar metabolites was inferred from both gene-dose and time-course experiments. Both initial and secondary metabolic steps after 4-oxo-all-trans-retinoic acid are ketoconazole-sensitive, suggesting that steps in the production of water-soluble metabolites are cytochrome P450-dependent. HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A.
引用
收藏
页码:1133 / 1142
页数:10
相关论文
共 43 条
[1]   The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures [J].
Abu-Abed, S ;
Dollé, P ;
Metzger, D ;
Beckett, B ;
Chambon, P ;
Petkovich, M .
GENES & DEVELOPMENT, 2001, 15 (02) :226-240
[2]   Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor γ and retinoid X receptor α [J].
Abu-Abed, SS ;
Beckett, BR ;
Chiba, H ;
Chithalen, JV ;
Jones, G ;
Metzger, D ;
Chambon, P ;
Petkovich, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2409-2415
[3]   4-Oxoretinol, a new natural ligand and transactivator of the retinoic acid receptors [J].
Achkar, CC ;
Derguini, F ;
Blumberg, B ;
Langston, A ;
Levin, AA ;
Speck, J ;
Evans, RM ;
Bolado, J ;
Nakanishi, K ;
Buck, J ;
Gudas, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (10) :4879-4884
[4]  
Barua AB, 1996, SKIN PHARMACOL, V9, P17
[5]   NORMAL-PHASE LC-MS DETERMINATION OF RETINOIC ACID DEGRADATION PRODUCTS [J].
BEMPONG, DK ;
HONIGBERG, IL ;
MELTZER, NM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (03) :285-291
[6]   A decade of molecular biology of retinoic acid receptors [J].
Chambon, P .
FASEB JOURNAL, 1996, 10 (09) :940-954
[7]  
DELEENHEER AP, 1990, METHOD ENZYMOL, V189, P104
[8]  
DOYLE JW, 1995, INVEST OPHTH VIS SCI, V36, P708
[9]   HUMAN SKIN LEVELS OF RETINOIC ACID AND CYTOCHROME P-450-DERIVED 4-HYDROXYRETINOIC ACID AFTER TOPICAL APPLICATION OF RETINOIC ACID INVIVO COMPARED TO CONCENTRATIONS REQUIRED TO STIMULATE RETINOIC ACID RECEPTOR-MEDIATED TRANSCRIPTION INVITRO [J].
DUELL, EA ;
ASTROM, A ;
GRIFFITHS, CEM ;
CHAMBON, P ;
VOORHEES, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1269-1274
[10]  
FIORELLA PD, 1994, J BIOL CHEM, V269, P10538